Exploratory Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Anti-mesothelin chimeric antigen receptor T cell therapy HRAIN Biotechnology/Zhejiang University (Primary) ; Cyclophosphamide; Fludarabine
- Indications Advanced breast cancer; Biliary cancer; Colorectal cancer; Endometrial cancer; Gastric cancer; Lung cancer; Male breast cancer; Malignant thymoma; Mesothelioma; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
Most Recent Events
- 13 Jun 2025 New trial record